Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
John M. Sprague currently holds 141 shares of T2 Biosystems, Inc. (TTOO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John M. Sprague has been a net seller of TTOO stock. They have purchased $4.8K and sold $15.8K worth of shares.
John M. Sprague's most recent insider trade was on Feb 24, 2024, when they sold 29 shares at $0.00 per share.
John M. Sprague serves as Executive at T2 Biosystems, Inc. (TTOO). They have executed 23 insider transactions totaling $20.6K over their tenure at the company.
John M. Sprague holds the position of Executive at T2 Biosystems, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 8 years and currently hold a stake valued at $0.
John M. Sprague has shown a selling trading pattern, with $4.8K in total purchases and $15.8K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by John M. Sprague was on Jul 20, 2018, when they sold $37.8K worth of TTOO shares. This transaction involved 5,619 shares at $6.72 per share.
John M. Sprague currently owns 141 shares of T2 Biosystems, Inc. (TTOO), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of John M. Sprague's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. John M. Sprague has 23 Form 4 filings on record as an insider at T2 Biosystems, Inc..
Set alerts for John M. Sprague and 40,000+ other insiders.